Showing 2141-2150 of 10467 results for "".
Enstilar Approved; New Data for Otezla, Duac
https://practicaldermatology.com/topics/psoriasis/dermwiretv-enstilar-approved-new-data-for-otezla-duac/18687/LEO Pharma's Enstilar (Calcipotriene and Betamethasone Dipropionate) Foam, 0.005%/0.064% has been FDA-approved for plaque psoriasis. New data presented at EADV on Stiefel's Duac, Celgene's Otezla, and Boehringer Ingelheim's investigational biologic compound BI 655066. Plus, Galderma's OTC Excipial lOnline Marketing Tips
https://practicaldermatology.com/topics/practice-management/online-marketing-tips/18690/Risa Goldman Luksa tells you what you need to know to ensure a solid foundation for your online marketing program.Color Your World
https://practicaldermatology.com/topics/practice-management/color-your-world/18833/The colors you use in your office and the style of your space-and your staff outfits-can all influence the perception of you and your practice. Heidi Waldorf, MD tells you how to give your space the attention it needs.Why Consider Lasers?
https://practicaldermatology.com/topics/practice-management/why-consider-lasers/18863/Should younger dermatologists add devices to their practice? Laser expert Eric Bernstein, MD talks about the decision to embrace technology and explains how it can mold the future of those who have a passion for lasers and other energy-based devices. Watch other PD Asks videos with Eric BernsteinDr. Kauvar Discusses Experience with Gemini Laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dr-kauvar-discusses-experience-with-gemini-laser/19469/“Treating with the Gemini is very well accepted by patients because both components of the Gemini, the 1064 and the 532nm, are non-invasive lasers. So there's really no real downtime and no recuperation, and the results are predictable in our hands, and patients are very satisfied with their treatThe Treatment Landscape for Children and Atopic Dermatitis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37153/Dawn Zhang Eichenfield, MD, PhD, a dermatologist at Rady Children's Hospital-San Diego and an assistant clinical professor of dermatology at the University of California, San Diego, School of Medicine, provides an overview of current therapeutic options for pediatric atopic dermatitis patients.Clinical Questions About Isotretinoin and More
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/clinical-questions-about-isotretinoin-and-more/54661/Lawrence Eichenfield, MD, discusses key takeaways from the “Acne and Rosacea: Update 2026” session at Maui Derm Hawaii 2026.Tips and Tricks for Prescribing Biologics for Pediatric Patients
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/tips-and-tricks-for-prescribing-biologics-for-pediatric-patients/54662/Dawn Eichenfield, MD, PhD, discusses key takeaways from the “Pediatric Dermatology 2026” session at Maui Derm Hawaii 2026.Updates on Psoriasis Biologics
https://reachmd.com/programs/practical-dermatology/updates-on-psoriasis-biologics/35894/Jashin J. Wu, MD, discusses biologics for psoriasis, including a meta-analyses of best biologics for different types of the condition, at Music City SCALE 2025.Cutaneous Toxicities in Graft-versus-host Disease
https://practicaldermatology.com/conferences/masterclasses-in-dermatology-2025/cutaneous-toxicities-in-graft-versus-host-disease/33013/Meghan Heberton, MD, an assistant professor of dermatology at UT Southwestern Medical Center, talks about her presentation at Masterclasses in Dermatology on the latest updates on cutaneous toxicities in Graft-versus-host (GvHD) disease.